In hepatocellular carcinomas, reduced FABP1 expression was linked to advanced stage (p = 0.0002), presence of lymph node metastasis (p = 0.0042), and female gender (p = 0.0002). The gene discussed is FABP1; the disease is metastatic malignant neoplasm in the lymph nodes.